Design and production of wax compensators for electron treatments of the chest wall

Dosimetric characterization of a rigid, surface-contour-specific thermoplastic bolus material

A dosimetric analysis of a commercially available thermoplastic sheet bolus, Klarity EZ Bolus^TM, was completed. Attenuation characteristics were evaluated using different configurations of a rectilinear water-mimicking plastic phantom irradiated by a high-energy linear accelerator using three photon energies, five electron energies. These results were compared with data obtained during the linear accelerator commissioning process to determine depths of water that attenuated beams similarly. CT scans of the flat, unmolded sheet bolus, as well as of the bolus molded to a cylindrical phantom, were analyzed. The product was found to form a durable and rigid, contour-specific bolus with a water-equivalent thickness of approximately 6 mm for a single sheet, and 11 mm for two sheets in tandem.

Measurement of Thyroid Dose by TLD arising from Radiotherapy of Breast Cancer Patients from Supraclavicular Field

BACKGROUND

Breast cancer is the most frequently diagnosed cancer and the leading global cause of cancer death among women worldwide. Radiotherapy plays a significant role in treatment of breast cancer and reduces locoregional recurrence and eventually improves survival. The treatment fields applied for breast cancer treatment include: tangential, axillary, supraclavicular and internal mammary fields.

OBJECTIVE

In the present study, due to the presence of sensitive organ such as thyroid inside the supraclavicular field, thyroid dose and its effective factors were investigated.

MATERIALS AND METHODS

Thyroid dose of 31 female patients of breast cancer with involved supraclavicular lymph nodes which had undergone radiotherapy were measured. For each patient, three TLD-100 chips were placed on their thyroid gland surface, and thyroid doses of patients were measured. The variables of the study include shield shape, the time of patient's setup, the technologists' experience and qualification. Finally, the results were analyzed by ANOVA test using SPSS 11.5 software.

RESULTS

The average age of the patients was 46±10 years. The average of thyroid dose of the patients was 140±45 mGy (ranged 288.2 and 80.8) in single fraction. There was a significant relationship between the thyroid dose and shield shape. There was also a significant relationship between the thyroid dose and the patient's setup time.

CONCLUSION

Beside organ at risk such as thyroid which is in the supraclavicular field, thyroid dose possibility should be reduced. For solving this problem, an appropriate shield shape, the appropriate time of the patient's setup, etc. could be considered.

An investigation of central axis depth dose distribution perturbation due to an air gap between patient and bolus for electron beams

Electron beams can be used for the radiotherapy treatment of superficial cancers. In many cases of electron beam radiotherapy, tissue equivalent bolus material placed on the skin is to be used to enhance skin dose. An air gap might be present between the bolus and the skin due to variation in the patient contour. The impact of semi-infinite air gaps under bolus material on central axis depth dose distributions for electron beams was investigated in this study. Semi-infinite air gaps were introduced between bolus and the surface of a water phantom for air gap sizes up to 20.0 mm and for bolus thicknesses of 5, 10 and 15 mm. The electron beams studied had nominal energies of 6, 10 and 14 MeV and circular fields of 3, 5, 7 and 9 cm diameter. Depth dose measurements were carried out in the water phantom with a Scanditronix p-Si electron diode. It was found that the impact of an air gap is dependent on beam energy, field size, air gap size and bolus thickness used. The impact of the air gap on central axis depth dose distribution increased with decreasing field size, increasing air gap size, decreasing electron beam energy and increasing bolus thickness. For 15 mm bolus, 3 cm diameter circular field, 6 MeV beam and the 20 mm air gap, the maximum dose and the surface dose was reduced by approximately 60% and the depth of dose maximum shifted 3.5 mm. An air gap between bolus and a patient should be avoided to ensure that there is no impact on the treatment. The measured data in this study can be used to determine the likely degree of impact on the treatment, of unavoidable air gaps between bolus and the patient.

Application of the electron pencil beam redefinition algorithm to electron arc therapy

This project investigated the potential of summing fixed-beam dose distributions calculated using the pencil-beam redefinition algorithm (PBRA) at small angular steps (1 degree) to model an electron arc therapy beam. The PRBA, previously modified to model skin collimation, was modified further by incorporating two correction factors. One correction factor that is energy, SSD (source-to-surface distance), and field-width dependent constrained the calculated dose output to be the same as the measured dose output for fixed-beam geometries within the range of field widths and SSDs encountered in arc therapy. Another correction factor (single field-width correction factor for each energy) compensated for large-angle scattering not being modeled, allowing a more accurate calculation of dose output at mid arc. The PBRA was commissioned to accurately calculate dose in a water phantom for fixed-beam geometries typical of electron arc therapy. Calculated central-axis depth doses agreed with measured doses to within 2% in the low-dose gradient regions and within 1-mm in the high-dose gradient regions. Off-axis doses agreed to within 2 mm in the high-dose gradient regions and within 3% in the low-dose gradient regions. Arced-beam calculations of dose output and depth dose at mid arc were evaluated by comparing to data measured using two cylindrical water phantoms with radii of 12 and 15 cm at 10 and 15 MeV. Dose output was measured for all combinations of phantom radii of curvature, collimator widths (4, 5, and 6 cm), and arc angles (0 degrees, 20 degrees, 40 degrees, 60 degrees, 80 degrees, and 90 degrees) for both beam energies. Results showed the calculated mid-arc dose output to agree within 2% of measurement for all combinations. For a 90 degree arc angle and 5 x 20 cm2 field size, the calculated mid-arc depth dose in the low-dose gradient region agreed to within 2% of measurement for all depths at 10 MeV and for depths greater than depth of dose maximum R100 at 15 MeV. For depths in the buildup region at 15 MeV the calculations overestimated the measured dose by as much as 3.4%. Mid-arc depth dose in the high-dose gradient region agreed to within 2.2 mm of measured dose. Calculated two-dimensional relative dose distributions in the plane of rotation were compared to dose measurements using film in a cylindrical polystyrene phantom for a 90 degree arc angle and field widths of 4, 5, and 6 cm at 10 and 15 MeV. Results showed that off-axis dose at the ends of arc (without skin collimation) agreed to within 2% in the low-dose gradient region and to within 1.2 mm in the high-dose gradient region. This work showed that the accuracy of the PBRA arced-beam dose model met the criteria specified by Van Dyk et al. [Int. J. Radiat. Oncol. Biol. Phys. 26, 261-273 (1993)] with the exception of the buildup region of the 15 MeV beam. Based on the present results, results of a previous study showing acceptable accuracy in the presence of skin collimation, and results of a previous study showing acceptable accuracy in the presence of internal heterogeneities, it is concluded that the PBRA arced-beam dose model should be adequate for planning electron arc therapy.